Bioxytran Inc (BIXT)

[Retire43]

Only time will tell how many viruses will be treatable as this new science gets into practice! There are so many viruses to be tackled!

[Retire43]

Tell everyone you know!

https://seekingalpha.com/instablog/1021634-agamemnus/5777326-ending-pandemic-cycle-bioxytran-s-bixt-galectin-approach

[misiu143]

Very good read..

https://seekingalpha.com/instablog/1021634-agamemnus/5777326-ending-pandemic-cycle-bioxytran-s-bixt-galectin-approach

GLTA longs

[Retire43]

I looked on OTC site as of 8/822
they show 133 beneficial shareholders!

That is a very small number of shareholders. I know 13 of them !

[Ecomike]

I feel a disturbance in the force. That usually means exciting news is coming.

$BIXT

[Retire43]

Yes! I am anticipating a new strain of Covid to come this winter!

Every flu and influenza season the US loses 200+ thousand people!

[Retire43]

You could be right! I’m hearing reports of increasing cases of Covid in a number of countries including India where there were Relatively few cases in 2020 and 2021!

[Ecomike]

I think the next mega wave of Covid19 and long haul covid his winter could run this $BIXT beast to $5/share

The stars are lining up fast..

[cheusmann]

Good dip opp here in my eyes.

[Ecomike]

They are buying at the bid and the ask nice and steady for weeks now too... $BIXT

[Ecomike]

Not if, but when folks

So here's my question. What if, during the month or two after a mild #Covid infection, certain people experience a major inflammatory event -- for example, a coagulation driven ischemia-reperfusion injury -- that causes microvascular damage leading to an #MECFS type #LongCovid? https://t.co/vdzSIQf4jS

— Jeffrey Lubell (EDS, ME/CFS, LongCOVID Research) (@JeffLubell_C19) September 4, 2022

Great hot of the press clues and explanation... and why next generation non toxic products (Rx) like $BIXT will be so important....

[Retire43]

People talking about BIXT

[Retire43]

Today was an amazing day! We made another higher high! A new all time high!

Closed on the high of the day !

All of this a very moderate volume!

[Retire43]

$1.25 high

[Retire43]

I like what I’m seeing, BIXT!

[Retire43]

18% gain on the day on just a lil more than 50K shares!

Where would we be if the bid side was 1M shares?

[i_like_bb_stock]

yes amazing

[Ecomike]

Starting to look like the sky is not a limit here $BIXT

[Ecomike]

This is the kind of news feed you only on major $$$$ Nasdaq Bio-tech drug stocks.

$BIXT

New Research on Bioxytran, Inc. (BIXT-OTCBB)

August 25, 2022 at 8:46 PM

An Executive Informational Overview (EIO) is now available on Bioxytran, Inc., a clinical stage pharmaceutical company developing therapeutics in two areas: (1) glycovirology and anti-viral therapeutics; and (2) hypoxic conditions, necrosis, and degenerative diseases. The 70-page report details the Company's business, its strategy, market opportunities, competition, financials, risks, and more. It is available for download below.

More here:

http://www.crystalra.com/blog/bioxytran-0-0-0-0-0-0?utm_campaign=Bioxytran

Here is peak at page 1

[Ecomike]

$BIXT is showing its strength as the market including OTC falters... going lower and lower.

Meanwhile BIXT is swimming upstream in style telling the market that the market is going the wrong way.

That confirms the DD on BIXT... about it's Solid Gold new Bio-tech science and new generation antivirals, targeting Covid19 for starters.

With new problems arriving like MonkeyPox and now this:

https://www.telegraph.co.uk/global-health/science-and-disease/mystery-pneumonia-kills-two-infects-six-argentina/

UNKNOWN PNEUMONIA—Very worrisome—3 people have died, 9 people infected, of which 8 medical workers, are in hospital after developing a “pneumonia of unknown origin”—Argentinian authorities announced. Not COVID or flu.

⚠️UNKNOWN PNEUMONIA—Very worrisome—3 people have died, 9 people infected, of which 8 medical workers, are in hospital after developing a “pneumonia of unknown origin”—Argentinian authorities announced. Not COVID or flu. #ArgentinaPneumonia

By @sneweyy https://t.co/UVBnbrbOZA pic.twitter.com/tYH10wTcs0

— Eric Feigl-Ding (@DrEricDing) September 1, 2022

He added that the six patients have had a series of tests for “Covid, cold, influenza of both types A + and B +, Hantavirus and 25 other germs” but no virus has yet been identified.

5) He added that the six patients have had a series of tests for “Covid, cold, influenza of both types A + and B +, Hantavirus and 25 other germs” but no virus has yet been identified. ⚠️

— Eric Feigl-Ding (@DrEricDing) September 1, 2022

The 8 medical workers is really bad news "3 people have died, 9 people infected, of which 8 medical workers" which is scary infectious....

If the medical workers got it that easy that is massively bad news....

And the monkeyPox just got a lot worse:

https://arstechnica.com/science/2022/08/monkeypox-encephalitis-deaths-probed-as-global-cases-top-25000/

Texas reports what may be the first U.S. death from monkeypox

https://www.cnbc.com/2022/08/30/texas-reports-what-may-be-the-first-us-death-from-monkeypox.html

Asymptomatic MonkeyPox is the clue the CDC and WHO missed, just like with Covid19 in 2020.

https://www.news-medical.net/news/20220817/Study-detects-asymptomatic-monkeypox-virus-infection.aspx

[highstakes]

Lol
This is a penny stock doesn’t trade the same

[Retire43]

Just bought more .901!

[i_like_bb_stock]

holding well

[Ecomike]

$BIXT is showing its strength as the market falters...

[Retire43]

Excellent!

[govprs]

Yeah

[misiu143]

Nice read..

https://microcapdaily.com/galectin-runners-bioxytran-inc-otcmkts-bixt-galectin-therapeutics-nasdaq-galt-breaking-out/

[i_like_bb_stock]

nice article http://www.crystalra.com/blog/bioxytran-0-0-0-0-0-0?utm_campaign=Bioxytran, Inc.&utm_content=219216924&utm_medium=social&utm_source=twitter&hss_channel=tw-57414051

[govprs]

https://www.otcmarkets.com/financialReportViewer?symbol=BIXT&id=344628

[Retire43]

This stock has broken highs!
6/4/19 it hit 1.95

I started buying this in October 2019 @ .82!

I believe in the CEO of this company!
He has a proven tract record!

[Retire43]

I had no idea this could have taken out all these previous highs !

Hoping for a close above 1.15 tomorrow! Only 100 shares traded at 1.15. Would love to see this !

[flacrusher]

People are starting to see what is possible here. Volume looking good. Happy to have a stake in this company

[i_like_bb_stock]

wowsa 1.05 close getting found finally

[Retire43]

We took out the 1/4/22 high of .75

Now let’s take out the 1.11 high 3/2/20

[i_like_bb_stock]

what a beauty heading to $1 test

[Retire43]

Yes!
Helping out the company and shareholders.

They get these drugs FDA approved or an EUA, they are millionaires!

[Ecomike]

That is impressive, most impressive:

Interesting facts from 10Q:

Found on page 15.

General and Administrative Expenses

Forfeited salaries and benefits

On August 1, 2022 the Company’s Management forfeited the majority of its accrued salaries and benefits for a total value of $1,273,000.


Our 3 board officers of the company just saved shareholders $1.2M !

[Retire43]

Wow!

I could see a huge pharma offering $50/sh

[Ecomike]

The only price I care about is the one I sell at, like $50/share but this a ways off.

For now the bears eating everything while the bulls rally $BIXT in recent days.

I can live with that LOL.

The $BIXT Bioxytran Beast is awakening

Gotta wonder what a 10 Mil share day of buying would do.

[Retire43]

Ok, let me see where everyone is thinking we are going to close this Friday August 26th!

[Ecomike]

$BIXT message to the shares on the ask:

[Retire43]

Wow. Up more than 38%

June and July highs have been taken out. Above them now!

January 4 th high .75

[Retire43]

Here is a replay of the interview!

;

[misiu143]

I just listened to yesterday presentation on Emerging Growth ,
link below..
It was very good .. Mike Sheikh was excellent with his presentation of efficacy and MOA , not only galectin 3 in Covid , but also in dementia , heart disease and other chronic diseases , I will listen for a second and the third time , as I want to understand better..
In Covid they see in the study 2-3 days later undetectable viral load , if these findings will be reproduce , this is very impressive..

And as a prognosis of severity in Covid , the higher is galectin 3 and 9 , the higher the mortality ..

It was a really good presentation , imo...

https://goto.webcasts.com/viewer/event.jsp?ei=1565190&tp_key=393dba9272

[Retire43]

New time for $Bixt EG conference

MIAMI, Aug. 16, 2022 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets announces the Schedule of the 37th Emerging Growth Conference.

The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.
Register for the conference here.
Submit your Questions for any of the presenting companies in advance to: [e-mail]

Be sure to reference the Company the question is directed to.
The schedule for August 17, 2022, is as follows:
(All times are Eastern Time Zone)
We may see some schedule changes on Wednesday. To stay current on the schedule,

Bioxytran (OTC Pink: BIXT)

Keynote speaker: Mike Sheikh, Executive Vice President of Business Development
12:45 – 1:15

[Retire43]

BIXT:


https://emerginggrowth.com/emerging-growth-conference-37/

[Retire43]

BIXT 10Q

[Retire43]

From the 10Q:

Found on page 16 .

ProLectin-M’s clinical data shows non-toxicity and efficacy for treatment of mild to moderate COVID-19. The results of the trial are described in our three peer-reviewed articles “Galectin antagonist use in mild cases of SARS-CoV-2; pilot feasibility randomised, open label, controlled trial”, published in Journal of Vaccines & Vaccination on December 30, 2020, “Carbohydrate ProLectin-M, a Galectin-3 Antagonist, Blocks SARS-CoV-2 Activity” published in the International Journal of Health Sciences on July 31, 2022 and “PLG-007 and Its Active Component Galactomannan-a Competitively Inhibit Enzymes That Hydrolyze Glucose Polymers” published in the International Journal of Molecular Science on July 13, 2022. The Company is currently working on a Phase III clinical trial with the CDSCO in India, and is preparing its IND with the FDA.

The clinical trials are expected to take place in August through September, 2022. Further, the Company is also preparing an CDSCO submission for a second drug candidate, ProLectin-I, with similar galectin blocking capabilities as the oral drug, ProLectin-M, but IV-injectable for pulmonary fibrosis. The initial Phase I/II clinical trial for ProLectin-I is planned for August through October, 2022. The described clinical trials are subject to additional funding.

——-
Please note the pulmonary fibrosis is a new drug

The ProLectin is one in oral dose the other is an Intravenous drug

[Retire43]

Interesting facts from 10Q:

Found on page 15.

General and Administrative Expenses

Forfeited salaries and benefits

On August 1, 2022 the Company’s Management forfeited the majority of its accrued salaries and benefits for a total value of $1,273,000.


Our 3 board officers of the company just saved shareholders $1.2M !

[Retire43]

Chart is looking good !